🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

9 recruiting trials

for Gaucher Disease, Type 1

Parkinson's Disease in Type 1 Gaucher Disease NCT07886879n/a1 site📍 New York Icahn School of Medicine at Mount Sinai Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC NCT04528355n/a1 site📍 Pittsburgh Paul Szabolcs · Tests: data collection A Clinical Study Evaluating LY-M001 Injection in the Treatment of Adult Patients With Type I Gaucher Disease NCT06818838Phase 1, Phase 23 sites📍 Guangzhou📍 Taiyuan📍 Tianjin Lingyi Biotech Co., Ltd. · Tests: LY-M001 A Study of the Safety and Preliminary Efficacy of LY-M001 Injection in the Treatment of Adult Patients With Gaucher Disease Type I NCT06162338NA1 site📍 Hanzhou He Huang · Tests: LY-M001 Injection Oxidative Stress and Inflammatory Biomarkers in Gaucher Disease NCT02437396n/a1 site📍 Minneapolis University of Minnesota A Gaucher Disease Gene Therapy Trial With FLT201 NCT07223944Phase 332 sites📍 Los Angeles📍 Los Angeles📍 San Francisco Spur Therapeutics · Tests: FLT201 Gaucherite - A Study to Stratify Gaucher Disease NCT03240653n/a8 sites📍 Birmingham📍 Birmingham📍 Cambridge Cambridge University Hospitals NHS Foundation Trust · Tests: Stratified response to Enzyme Therapy Prodromal Parkinsonian Features in GBA1 Mutation Carriers NCT05253560n/a1 site📍 Jerusalem Shaare Zedek Medical Center · Tests: The investigators aim to identify prodromal PD in a cohort of carriers of Gaucher disease. Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT NCT01962415Phase 21 site📍 Pittsburgh Paul Szabolcs · Tests: Hydroxyurea, Alemtuzumab, Fludarabine, Melphalan, Thiotepa
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy